0.4323
0.0084 (1.98%)
0.0084 (1.98%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sunesis Pharmaceuticals Inc | SNSS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.0084 | 1.98% | 0.4323 | 0.422 | 0.446 | 0.4222 | 0.4239 | 10:14:05 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.4301 | 0.4351 | 0.005 | 1.15% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 102 | 62,310 | $ 0.4355178 | $ 27,137 | 1,849,419 | 0.1951 - 1.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:14:05 | 185 | $ 0.4323 | USD |
Sunesis Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 47.22M | 111.39M | $ -26.62M | -0.29 | - | 109.40M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 1.80% |
Sunesis Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNSS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4399 | 0.50 | 0.405 | 0.4319008 | 520,031 | -0.0076 | -1.73% |
| 1 Month | 0.47 | 0.62 | 0.305 | 0.4179502 | 1,101,290 | -0.0377 | -8.02% |
| 3 Months | 0.48 | 1.17 | 0.305 | 0.6856736 | 1,537,139 | -0.0477 | -9.94% |
| 6 Months | 0.6599 | 1.17 | 0.1951 | 0.5209482 | 1,701,754 | -0.2276 | -34.49% |
| 1 Year | 1.57 | 1.70 | 0.1951 | 0.6434372 | 1,251,030 | -1.14 | -72.46% |
| 3 Years | 3.85 | 7.69 | 0.1951 | 1.04 | 614,256 | -3.42 | -88.77% |
| 5 Years | 2.65 | 7.69 | 0.1951 | 1.29 | 590,366 | -2.22 | -83.69% |
Sunesis Pharmaceuticals Description
| Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements. |
